Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **scalp vasculature** refers collectively to the network of arteries and veins supplying blood to the skin, connective tissue, and underlying structures covering the skull. It is not a single molecule or receptor but an anatomical system composed primarily of branches from the external carotid artery—namely, the superficial temporal artery, posterior auricular artery, occipital artery—and branches from the internal carotid via its ophthalmic branch (supratrochlear and supraorbital arteries). Venous drainage occurs through similarly named veins that ultimately drain into jugular venous systems. This extensive vascular network provides robust perfusion necessary for hair growth, thermoregulation, wound healing, and protection against infection. The dense interconnections also mean that injuries can result in significant bleeding. Certain congenital or acquired conditions can affect these vessels—such as hemangiomas or telangiectasias—but there are no known drugs designed specifically for this anatomical target. Because "scalp vasculature" is not a discrete molecular entity but rather an anatomical feature comprising many vessel types (arteries/capillaries/veins), it does **not qualify as a therapeutic target like receptors or enzymes**, nor does it have canonical abbreviations or direct drug interactions typical for molecular targets.
Not applicable for this anatomical structure. General mechanisms include: - Vasoconstriction/vasodilation by systemic agents (e.g., local anesthetics with epinephrine for hemostasis during surgery)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scalp vasculature (None).